These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 33612044)
21. Developing plant-based vaccines against neglected tropical diseases: where are we? Rosales-Mendoza S; Govea-Alonso DO; Monreal-Escalante E; Fragoso G; Sciutto E Vaccine; 2012 Dec; 31(1):40-8. PubMed ID: 23142588 [TBL] [Abstract][Full Text] [Related]
22. Perspectives of vaccination in Chagas disease revisited. Camargo EP Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():275-80. PubMed ID: 19753485 [TBL] [Abstract][Full Text] [Related]
23. Inducible suicide vector systems for Trypanosoma cruzi. Ma Y; Weiss LM; Huang H Microbes Infect; 2015 Jun; 17(6):440-50. PubMed ID: 25899945 [TBL] [Abstract][Full Text] [Related]
24. Protection against Trypanosoma cruzi using fecal forms of homologous parasites from juvenilized or normal vectors of Chagas' disease and by passive transfer of immune blood. Perlowagora-Szumlewicz A Rev Bras Malariol Doencas Trop; 1977; 29():5-21. PubMed ID: 120952 [No Abstract] [Full Text] [Related]
25. Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge. Collins MH; Craft JM; Bustamante JM; Tarleton RL Infect Immun; 2011 Aug; 79(8):3397-406. PubMed ID: 21628516 [TBL] [Abstract][Full Text] [Related]
26. [Protection of mice with Trypanosoma lewisi antigen and its fractions against experimental Trypanosoma cruzi infection]. Fernández de Lara WG Rev Inst Med Trop Sao Paulo; 1972; 14(5):301-5. PubMed ID: 4630386 [No Abstract] [Full Text] [Related]
27. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection. Sepulveda P; Hontebeyrie M; Liegeard P; Mascilli A; Norris KA Infect Immun; 2000 Sep; 68(9):4986-91. PubMed ID: 10948115 [TBL] [Abstract][Full Text] [Related]
28. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi. Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413 [TBL] [Abstract][Full Text] [Related]
32. Dinitroaniline herbicides against protozoan parasites: the case of Trypanosoma cruzi. Traub-Cseko YM; Ramalho-Ortigão JM; Dantas AP; de Castro SL; Barbosa HS; Downing KH Trends Parasitol; 2001 Mar; 17(3):136-41. PubMed ID: 11286798 [TBL] [Abstract][Full Text] [Related]
33. Understanding CD8 Acosta Rodríguez EV; Araujo Furlan CL; Fiocca Vernengo F; Montes CL; Gruppi A Trends Parasitol; 2019 Nov; 35(11):899-917. PubMed ID: 31607632 [TBL] [Abstract][Full Text] [Related]
34. Mother-to-child transmission of Trypanosoma cruzi infection (Chagas disease): a neglected problem. Norman FF; López-Vélez R Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):388-90. PubMed ID: 24771504 [TBL] [Abstract][Full Text] [Related]
35. Differences in inferred genome-wide signals of positive selection during the evolution of Trypanosoma cruzi and Leishmania spp. lineages: A result of disparities in host and tissue infection ranges? Flores-López CA; Machado CA Infect Genet Evol; 2015 Jul; 33():37-46. PubMed ID: 25891283 [TBL] [Abstract][Full Text] [Related]
36. Strongyloides stercoralis and Trypanosoma cruzi coinfections in a highly endemic area in Argentina. Fleitas PE; Floridia-Yapur N; Nieves EE; Echazu A; Vargas PA; Caro NR; Aveldaño R; Lopez W; Fernandez M; Crudo F; Cimino RO; Krolewiecki AJ PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010179. PubMed ID: 35120117 [TBL] [Abstract][Full Text] [Related]
37. The vaccine potential of cell surface glycoproteins from Trypanosoma cruzi. Scott MT; Neal RA Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):63-72. PubMed ID: 6151689 [TBL] [Abstract][Full Text] [Related]
38. Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection. Farrow AL; Rachakonda G; Gu L; Krendelchtchikova V; Nde PN; Pratap S; Lima MF; Villalta F; Matthews QL PLoS Negl Trop Dis; 2014 Aug; 8(8):e3089. PubMed ID: 25144771 [TBL] [Abstract][Full Text] [Related]
39. Induction of Effective Immunity against Trypanosoma cruzi. Williams T; Guerrero-Ros I; Ma Y; Matos Dos Santos F; Scherer PE; Gordillo R; Horta A; Macian F; Weiss LM; Huang H Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31907197 [TBL] [Abstract][Full Text] [Related]
40. A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease. Serna C; Lara JA; Rodrigues SP; Marques AF; Almeida IC; Maldonado RA Vaccine; 2014 Jun; 32(28):3525-32. PubMed ID: 24793944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]